Powered by


                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Health Questions

   News via RSS






   Forum Archives





















   Primary Care






   Other Sections


   Research Tools

   Medical Tutorials

   Medical Software




Back to index

Cancer Chemotherapy Regimen for Breast Cancer

 AVM                                                    breast(15)
  adriamycin...... 30 mg/sqm IV day 1 and 28.
  vinblastine..... 6 mg/sqm IV day 1 and 18.
  mitomycin....... 10 mg/sqm IV day 1.
  FREQUENCY....... Repeat cycle every 8 weeks.

    Luikart SD.  Witman GB.  Portlock CS. Adriamycin 
    (doxorubicin), vinblastine, and mitomycin C combination 
    chemotherapy in refractory breast carcinoma. Cancer.  
    54(7):1252-5, 1984 Oct 1. 
    Twenty-seven evaluable patients with refractory, metastatic 
    breast carcinoma were treated with Adriamycin (doxorubicin) 30 
    mg/m2 and vinblastine 6 mg/m2 intravenously on days 1 and 28 
    every 8 weeks, and mitomycin C 10 mg/m2 intravenously on day 1 
    every 8 weeks (AVM). There were three complete and six partial 
    responses for a total response rate of 33%. In addition, 2 
    patients had minimal responses, and 10 patients achieved 
    disease stabilization. Median time to disease progression for 
    responders was 116 days (range, 49-812+ days). Drug toxicity 
    was tolerable: 12 patients (44%) experienced significant bone 
    marrow suppression. There were no drug-related deaths. 
    Although AVM appears to be an active drug combination in 
    heavily pretreated patients with metastatic breast carcinoma, 
    the contribution of vinblastine and mitomycin C to single 
    agent Adriamycin in previously treated patients is not clear 
    from this study. 
advertisement.gif (61x7 -- 0 bytes)

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


 advertisement.gif (61x7 -- 0 bytes)




We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright 2001-2012 DoctorsLounge. All rights reserved.